Search:
 
SHARE PRINT

Evaluation

For an alliance whose innovative methods are often held up as models for others to imitate, it is essential that GAVI evaluates "lessons learned". It does this through commissioned studies and is guided by its evaluation policy.

From new types of funding to ground-breaking partnerships, the GAVI Alliance has built a reputation for "thinking outside the box" in its efforts to deliver life-saving vaccines in the world’s poorest countries. Evaluation offers the Alliance the opportunity to measure what has worked and why.

Recent evaluation studies

The GAVI Alliance commissioned evaluations of:

  • Health System Strengthening (HSS)
  • Health System Strengthening (HSS) Tracking Study
  • GAVI Phase One (GAVI's work in 2000-2005).
  • Immunisation Services Support (ISS)
  • Injection Safety Support (INS)
  • The Accelerated Development and Introduction of Priority New Vaccines (ADIPs), the Hib Initiative, and related support for the introduction of new vaccines

Here is the latest on these evaluations:

  1. Health System Strengthening (HSS)

    The Health System Strengthening Evaluation was completed in October 2009, and shared with the GAVI Board in November 2009. Volume 1 (PDF - 532KB) contains the main findings and recommendations while Volume 2 (PDF - 1.617MB) is the full report.

    You can also view the Evaluation Secretariat response (PDF - 81.51KB) and the World Bank response (PDF - 31.42KB).

    Visit the GAVI website's Country Data section to find HSS Evaluation country reports for the following 21 countries: Bhutan, Burundi, Cambodia, DR Congo, Ethiopia, Georgia, Ghana, Honduras, Kenya, Kyrgyzstan, Liberia, Nepal, Nicaragua, Nigeria, Pakistan, Rwanda, Sierra Leone, Sri Lanka, Vietnam, Yemen, Zambia.

  2. Health System Strengthening (HSS) Tracking Study

    The tracking study (PDF - 908KB) was undertaken as a complementary more in depth country perspective that helped highlight implementation issues in 6 countries.

    The in-depth country reports for these six countries (DR Congo, Ethiopia, Kyrgystan, Nepal, Vietnam and Zambia) are available under the country specific information on the website.

  3. GAVI Phase One (2000-2005).

    The evaluation report (PDF - 3MB) was completed, and after a review process by the GAVI Evaluation Steering Committee, was discussed by the GAVI Board in March 2009.

    Here is the executive summary of the evaluation study (PDF - 120K) and the GAVI management response (PDF -60K).

    Work is ongoing to implement the agreed recommendations and develop the further actions required.

  4. Immunisation Services Support (ISS).

    Summary of results and findings
    The evaluation report (PDF - 628K) was completed, and then went through a review process by the ISS Steering Committee (September 2007) and the GAVI Working Group (October 2007).

    The GAVI Senior Management team prepared a formal response (Excel - 32K) to the recommendations for the GAVI Alliance Boards in November 2007. Work is ongoing to implement the agreed recommendations and develop the further actions required.

  5. Injection Safety Support (INS) has also been evaluated, with the evaluation being overseen by the GAVI's Injection Safety Support Steering Committee.

    The objectives of the evaluation were to:

    • describe the decision-making process regarding the replacement of GAVI INS support
    • assess how and to what extent countries have replaced GAVI support during the first year (or more) after GAVI INS support ended
    • determine how countries have replaced GAVI INS support in a sustainable manner
    • assess the effect of the GAVI INS support on the broader health sector at the country level; and
    • determine how cash funds have supported the implementation of country INS plans of action.

      Read the report of the INS evaluation (PDF - 1.6MB)

  6. The Accelerated Development and Introduction of Priority New Vaccines (ADIPs), the Hib Initiative, and related support for the introduction of new vaccines.

    The ADIPs evaluation study was completed, the report (PDF - 390K)endorsed by the board in May 2007 and a managerial response (PDF - 56K) given.

GAVI's evaluation policy

The GAVI Alliance evaluation policy (PDF - 57K) guides how GAVI accesses its activities from 2008 onwards (GAVI Phase Two).

The policy has been developed by the GAVI secretariat and the Monitoring and Evaluation Technical Advisory Group (METAG) and has been reviewed by the GAVI Working Group.

Criteria

As well as defining the objectives of GAVI evaluations in the context of the alliance’s overall mission, the policy also identifies which GAVI activities will be assessed; this list includes projects, programmes and policies.

Criteria for each evaluation include relevance, efficiency, effectiveness, impact – negative or positive – and sustainability.

The policy also helps the alliance consider when evaluations should be carried out and by whom: during a policy’s implementation or afterwards; by internal staff or outsourced; in a participatory manner or jointly among partners.

Knowledge-sharing

The policy also enables partners to carry out their own evaluations, emphasizing the importance of knowledge-sharing across the Alliance. It also outlines how external evaluators should be selected and gives guidance on conflict of interest and transparency issues.

All GAVI evaluations are carried out according to international standards, guaranteeing independence, impartiality and transparency.